1.Association rules: Comorbid chronic diseases among the elderly
Uuganbayar O ; Purevdolgor L ; Ajnai L ; Javzmaa Ts ; Odgerel B ; Baasandorj Ch
Mongolian Journal of Health Sciences 2025;88(4):248-252
		                        		
		                        			Background:
		                        			The aging of the world’s population will determine global health trends. According to the 2021 report of the 
Capital City Health Department, the average life expectancy of the Mongolian population is 71.3 years (male 67.3, female 
76.7), the difference between male and female life expectancy is 9.4 years, and elderly people aged 60 and over account 
for 8.1% of the total population. The report also shows that 6.5% of all outpatient visits are for people aged 60-64, and 9% 
are for people aged 65 and over, which means that they do not receive adequate health care services. Therefore, it is important to increase the access to and quality of health care services provided to the elderly in order to improve their health 
and quality of life. Comorbidities that are common among the elderly are one of the pressing issues in the health sector. 
		                        		
		                        			Aim:
		                        			We aimed to study the prevalence and risk factors of multi-morbidities among older adults (aged sixty years and 
over) in urban and rural areas.
		                        		
		                        			Materials and Methods:
		                        			To accomplish our aim, we conducted 156 lifestyle related questionnaires and 18 health related 
questionnaires among 720 older people in Ulaanbaatar city and rural areas, and created the database. Pearson correlation 
coefficient was used to determine the relationship between the quantitative influence of factors using single and multi-factor linear (β-coefficient) and binary logistic regression (odds ratio, CI 95%) methods, and p value less than 0.05 was considered statistically significant. The Apriori algorithm in SPSS was used to determine the relationship between multiple 
chronic diseases in the elderly people.
		                        		
		                        			Results:
		                        			The prevalence of comorbidity was higher in urban areas (48.1%) and rural areas (51.9%), and ageing (urban 
areas OR: 2.45, 95% CI: 0.9-6.2; rural areas OR: 6.35, 95% CI: 1.47-27.4, P<0.01) was a risk factor of multi-morbidities. Multimorbidity is defined as the presence of 2 or more chronic conditions, and 3, 4, and 5 chronic conditions were 
co-occurred to older adults with chronic conditions, 28.7% (165). 11 common patterns of relationships in urban areas and 
18 common patterns of relationships in rural areas (support (A→B)>3%, confidence (A→B)>30%, lift (A→B)>1) were 
determined.
		                        		
		                        			Conclusion
		                        			Multimorbidity was different in urban and rural areas, 11 common patterns in urban areas and 18 common 
patterns in rural areas were determined. It has shown that the prevalence of multimorbidity was different in urban and 
rural areas.
		                        		
		                        		
		                        		
		                        	
2.Prevalence of iron deficiency and iron deficiency anemia in patients with hemophilia
Narangerel B ; Ankhbayar D ; Munkhuu A ; Burenbayar Ch ; Odgerel Ts
Mongolian Journal of Health Sciences 2025;86(2):42-45
		                        		
		                        			Background:
		                        			Iron deficiency (ID) and iron deficiency anemia (IDA) are among the most common forms of anemia
worldwide. Although the underlying causes of ID may vary depending on a country’s developmental level, lifestyle, and
other factors, blood loss remains the principal cause leading to ID and subsequent IDA. In hemophilia, recurrent bleeding
due to deficiencies of coagulation factors (FVIII, FIX, FXI) can lead to ID, which may progress to IDA and adversely
affect the quality of life in these patients. The absence of studies evaluating the prevalence of ID and IDA among hemophiliac
patients in Mongolia provided the impetus for this investigation.
		                        		
		                        			Aim:
		                        			To assess the prevalence of ID and IDA among patients with hemophilia.
		                        		
		                        			Materials and Methods:
		                        			A cross-sectional study was conducted among 45 patients with hemophilia registered at the Hemophilia
Comprehensive Center (HCC), Mongolia-Japan Hospital, Mongolian National University of Medical Sciences.
All participants underwent laboratory testing, including complete blood count (CBC) and serum ferritin levels—were
performed using the SYSMEX XN2000 and COBAS BM6010 analyzers. Data analysis was carried out using SPSS 27.0
and MS Excel 2010.
		                        		
		                        			Results:
		                        			Among the 45 cases, 41 were Hemophilia A and 4 were Hemophilia B. Reduced serum iron levels were found in
33.3% (15), and low ferritin levels were observed in 22.2%. Detailed blood tests revealed microcytic hypochromic changes
in 43.9% (18) of Hemophilia A cases and in 100% (4) of Hemophilia B cases. The overall prevalence of ID was 13.3%,
while the prevalence of IDA was 22.2%. Among the IDA cases, 90.0% were classified as mild and 10.0% as moderate.
Notably, 80.0% of the IDA cases occurred in children under 15 years of age.
		                        		
		                        			Conclusion
		                        			ID and IDA are common among hemophiliac patients. The high prevalence among children under 15 years
of age suggests an age-related predisposition, emphasizing the need to improve disease management and to implement
preventive measures against anemia in this population.
		                        		
		                        		
		                        		
		                        	
3.Management and monitoring of hypokalemia occurring during certain diseases
Temuulen Ts ; Maral B ; Baasanjargal B ; Agidulam Z ; Burenbayar Ch ; Ankhbayar D ; Tsogdulam S ; Amardulguun S ; Otgon-Erdene M ; Anujin G ; Khongorzul U1 ; Delgermaa Sh ; Odgerel Ts
Mongolian Journal of Health Sciences 2025;86(2):51-54
		                        		
		                        			Background:
		                        			Hypokalemia is considered when the serum potassium level is less than 3.5 mmol/L. Clinical research indicates
that hypokalemia affects 20% of hospitalized patients, and in 24% of these cases, inadequate interventions result
in life-threatening complications. At present, there is no research available on the prevalence, management, and outcomes
of hypokalemia in hospitalized patients, which justifies the need for this study.
		                        		
		                        			Aim:
		                        			The study aimed to examine the prevalence of hypokalemia and the effectiveness of its management in hospitalized
patients within the internal medicine department, in relation to the knowledge of doctors and resident physicians.
		                        		
		                        			Materials and Methods:
		                        			This hospital-based retrospective study included a total of 553 cases of patients hospitalized in
the Internal Medicine Department of the Mongolia Japan Hospital between January 2024 and August 2024. Patients with
a potassium level of <3.5 mmol/L were diagnosed with hypokalemia, and the effectiveness of potassium replacement
therapy was evaluated according to the method of supplementation employed.
		                        		
		                        			Results:
		                        			The prevalence of hypokalemia among hospitalized patients in the Internal Medicine Department was 9.8%
(54 cases). Based on the study criteria, 42 cases of hypokalemia were selected for further analysis, and a total of 118 potassium
replacements were performed through oral, intravenous, and mixed methods. Following potassium replacement
therapy, 37.3% (44) of patients achieved normalized potassium levels, while 62.7% (74) still had persistent hypokalemia.
		                        		
		                        			Conclusion
		                        			According to the study results, the prevalence of hypokalemia among hospitalized patients in the Internal
Medicine Department is 9.8%. The method of potassium replacement and the severity of hypokalemia do not impact the
normalization of potassium levels, with the critical factor being the proper dosage of supplementation. The knowledge
of doctors and resident physicians regarding hypokalemia is insufficient, and there is a need to implement guidelines and
protocols for potassium replacement therapy in daily clinical practice.
		                        		
		                        		
		                        		
		                        	
4.The prevalence and severity of anemia among adults
Enkhmaa B ; Khulan P ; Oyunsuren E ; Odgerel TS ; Uranbaigali E
Mongolian Journal of Health Sciences 2025;86(2):97-101
		                        		
		                        			Background:
		                        			Anemia is still being a population’s challenging issue regardless of high development of countries around
the world. According to a study regarding prevalence and etiology of anemia conducted in 187 countries around the
world, the anemia rate is 23 176 per 100 000 population. In accordance with the “5th National Nutrition Survey” study
conducted in our country in 2017, one of every five women (21.4%), aged 15-49 years, 16.2% of reproductive age women
and 3.0% of men are anemic. The current study was conducted due to it is still essential to study and identify the etiology
of anemia, determine its prevalence, plan appropriate intervention, and organize future preventive measures, depending
on the socio-economic conditions, location, diet, and customs of the Mongolians.
		                        		
		                        			Aim:
		                        			To identify anemia among the adult population, determine the type and severity of anemia.
		                        		
		                        			Materials and Methods:
		                        			The cross sectional study was conducted during between May 2022 and Sep 2023 and adults
aged above 18 years were included. Moreover, we identified anemia cases based on the laboratory test results and determined
the anemia severity grade. Statistical analysis was performed by using SPSS software.
		                        		
		                        			Results:
		                        			Among the participants, 6.7% of them, 9.9% of females and 2.8% of males are anemic. Prevalence of mild,
moderate and severe anemia is 66.7%, 30% and 3.3%, respectively. While the prevalence of anemia among reproductive
age women is higher, the prevalence of anemia increases with age. The anemia prevalence in Ulaanbaatar region, Western
region, Khangai mountainous region, Central region and Eastern region is 583 (25.6%); 171 (7.5%); 343 (15.1%); 921
(40.4%); and 261 (11.4%), respectively. By regional location, the prevalence is high in the Central region, with varying
prevalence in other regions.
		                        		
		                        			Conclusion
		                        			Anemia was detected in 6.7% of the total study population, 9.9% of females, and 2.8% of males were anemic.
Of those with anemia, 66.7% had mild anemia, 30% had moderate anemia, and 3.3% had severe anemia. Moderate
and severe anemia were more common in females than in males.
		                        		
		                        		
		                        		
		                        	
5.The Correlation Between Prognostic Indicators of Chronic Liver Diseases and Certain Blood Test Parameters
Munkhtsetseg M ; Allabyergyen M ; Temuulen Ts ; Narangere .B ; Temuulen E ; Sumiyabazar A ; Bolormaa B ; Munkhuu A ; Dorjzodov D ; Munkhbat R ; Odgerel Ts
Mongolian Journal of Health Sciences 2025;86(2):191-195
		                        		
		                        			Background:
		                        			Hepatocellular carcinoma (HCC) is a primary liver cancer originating from liver cells, classified as a chronic
liver disease. This cancer ranks third in the world in terms of mortality rate. The MELD (Model for End-Stage Liver
Disease) and Child-Pugh scoring systems are utilized to assess the prognosis of chronic liver diseases. Based on studies
suggesting that certain blood test indicators, particularly red cell distribution width (RDW), could be used to predict the
prognosis of liver cancer and other cancers, as well as serve as diagnostic markers, this topic was chosen to evaluate the
clinical significance of RDW in hepatocellular carcinoma.
		                        		
		                        			Aim:
		                        			The aim is to study some blood test indicators and compare them with the MELD score and Child-Pugh score systems
in order to determine the prognosis of chronic liver diseases.
		                        		
		                        			Materials and Methods:
		                        			A retrospective, single-center, cross-sectional study was conducted at Mongolia-Japan Hospital.
Among 322 patients diagnosed with HCC, 24 patients were selected for the case group, and 37 patients with liver cirrhosis
were included in the control group.
		                        		
		                        			Results:
		                        			According to the research criteria, 61 patients were selected and divided into 3 groups, and statistical analysis
was performed. In the detailed blood test, platelet count and WBC count showed statistically significant differences
among the 3 groups (p< 0.024). In the biochemical tests, C-reactive protein (CRP) was p< 0.018, total bilirubin p< 0.001,
and the mean albumin level p< 0.015, all showing statistically significant differences among the 3 groups. A statistically
significant inverse correlation was observed between RDW-CV and the clinical MELD score (r=-0.356).
		                        		
		                        			Conclusion
		                        			Platelet count, RDW, CRP, total bilirubin, and average albumin levels are significantly different across the
studied groups. RDW-CV shows a moderate inverse correlation with MELD scores, suggesting its potential as a prognostic
marker in chronic liver diseases. Further research with larger sample sizes is recommended to confirm these findings.
		                        		
		                        		
		                        		
		                        	
6.Determination of JAK2 V617F gene mutation for diagnosis of polycythemia vera
Tsogjargal B ; Sarantsetseg J ; Odgerel Ts
Health Laboratory 2022;15(1):1-5
		                        		
		                        			Introduction:
		                        			Polycythemia vera (PV) is Philadelphia chromose (Ph)-negative and chronic myeloproliferative disorder (MPN). Moreover, 0.01-2.6 incidences are diagnosed for every 100,000 population. In Polycythemia vera, guanine on 1849th base of 14th ex-one of 9th hromosome is replaced by thymidine and homozygous state is developed. As a result, valine on 617 of JH2 domain in JAK2 is replaced by fenylalanine and activation of tyrosine kinase is increased. Then, signal pathways such as JAK-STAT, PI3K/Akt and ERK1 are independently activated. The JAK2 V617F mutation is identified in approximately 95% of total polycythemia vera diagnosed cases. Furthermore, the average age group of patients with polycythemia vera is 61 and 10% of them are aged under 40 years and male:female ratio is 1:1. 
In accordance with World Health Organization criteria of 2016: If three major criterias or first two criteria plus one minor criteria are identified, Polycythemia vera is diagnosed. 
Although life expectancy rate of PV cases in follow-up is high, is lower in comparison with the general same age group of population and essential thrombocythemia (ET). In accordance with an international and large study (n=1545), the average life expectancy rate was 14.1 years among Polycythemia Vera diagnosed patients. More than half of mortality related to the disorder (53%) was caused by unknown etiology. On the other hand, (36\347, 10.3%), (36\347, 10.3%), (32\347, 9.2%) and (13\347, 3.7%) of the remaining mortality cases were caused by acute leukemia, secondary malignancy, thrombotic complications and cardiac failure, respectively.
		                        		
		                        			Objective:
		                        			We aimed to determine JAK2 V617F gene mutation on patients with suspected polycythemia vera 
and evaluate the CBC/complete blood count/ parameters and clinical signs. 
		                        		
		                        			Material and method:
		                        			The cross sectional study was conducted during 8/Mar/2022 ad 20/May/2022 and 13 individuals with suspected polycythemia vera who received outpatient service at hematology department of State First Central hospital (SFCH) and Mongolia-Japan hospital of MNUMS were included. Ethical approval was received by order (№2022/3-02) of 28/Feb/2022 and research ethics review committee. Each and every participant received informed consents and agreed to participate in the study. The current study was conducted with the support of integrated laboratory of Clinical pathology of State First central hospital. 
		                        		
		                        			Result
		                        			Total of 13 participants were included in the study, 38.4% (n=5) and 61.5% (n=8) of them were male and females, respectively. The mean age group was 58.69±7.7 years. The JAK2 V617F mutation was detected in 92.3% (12/13) of patients. The average age group was 57.8 (52-68) for males and 58.6 (43-71) for females. Complete blood count parameters of males with the JAK2 V617F mutation are shown. 
By questionnaire, some of clinical signs such as fatigue, pruritus after bath, headache, dizziness, bone and muscle pain, hands and feet peripheral cyanosis, numbness and nocturnal sweating were detected on patient with positive mutation.
		                        		
		                        		
		                        		
		                        	
7.Study report of deseas history pacients administrated in “Gurvan gal” hospital with diagnosis of rotaviruses
Odgerel B ; Oyungerel S ; Ulziitsetseg Ts ; Bayarjavkhlan Ch
Health Laboratory 2022;16(2):16-21
		                        		
		                        			Introduction:
		                        			Diarrhea is defined as a person excretes more than three times in 24 hours with pathological impurities of more than 10 mg/kg per day. According to the fact sheets of the World Health Organization in 2019, diarrhea is the second leading cause of death among children under 5 years of age. Researchers suggest that about 50 percent of infantile diarrhea occurs in temperate countries and it reaches almost 80 percent in winter which is mainly caused by rotavirus. While immunization is the most effective way to prevent rotavirus infection, there were two types of rotavirus vaccines that have been licensed and available on the global market since 2006. Rotavirus immunization in young children is a safe and effective public health method for controlling rotavirus infection which therefore can reduce childhood morbidity and mortality.
		                        		
		                        			Study aim:
		                        			To study the incidence, clinical manifestations, and complications of rotavirus among children hospitalized with acute diarrhea.
		                        		
		                        			Methodology:
		                        			The study will be conducted using the observational method including descriptive analysis. Statistical data for 2018-2020 will be obtained and analyzed from the pediatric wards of the “Gurvan Gal” hospital. Children diagnosed with rotavirus diarrhea who meet the criteria to be included in the study will be selectively sampled with further analysis of the incidence, clinical features, toxicity, and dehydration of acute diarrhea according to the medical history.
		                        		
		                        			Results
		                        			Universal immunization is important to significantly reduce rotavirus-associated diarrhea, thereby reducing infection and the risk of disease in infants and young children.
		                        		
		                        		
		                        		
		                        	
8.Significance of platelet parameters in the diagnosis of pediatric complicated acute appendicitis
Ganbayar G ; Baatarsuren B ; Erdenetsetseg Ch ; Bayartsetseg A ; Odgerel Ts
Innovation 2021;15(1):16-19
		                        		
		                        			Background:
		                        			Acute appendicitis is an inflammatory disease and acommon cause of acute 
abdominal pain. The application of the sophisticated automated hematology analyzer more 
precisely define the morphology changes blood cells. According to this diagnose and treatment 
control issues are solved by easy and not expensive way. Recent studies haveshown that there is a 
negative correlation between platelet count (PC) and MPV and that theratio of these two values 
may be more meaningful. The aim of our study was to investigate thediagnostic value of MPV and 
the MPV/PC ratio in acute appendicitis. 
		                        		
		                        			Methods:
		                        			The patients were divided into two groups based on their histopathological findings: 
the uncomplicated and complicated appendicitis groups. Leukocyte count, PC, MPV and the 
MPV/PC ratio were compared all groups.
		                        		
		                        			Results:
		                        			Total of 186 patients, including 119 men, were included in the study. The average age of 
all patients was 10.21±1.22 years. There was statistically significant difference of some parameters 
in peripheral blood between the uncomplicated and complicated appendicitis groups in terms 
of all index. (p<0.001). Leukocyte count had a strong discriminatory property based on the area 
under curve (AUC) 0.714, (p<0.001). MPV, PC and the MPV/PC ratio had weak discriminatory 
power with AUC values <0.663. Using receiver operating characteristic (ROC) analysis, the 
sensitivity and specificity of MPV were 81.56and 45.7%, respectively, and 63.78% and 71.06%, 
respectively, for the MPV/PC ratio.
		                        		
		                        			Conclusions
		                        			In our study, MPV and the MPV/PC ratio were useful in the diagnosis of acute 
appendicitis.
		                        		
		                        		
		                        		
		                        	
9.COMPARISON OF VALUE OF RED CELL DISTRIBUTION WIDTH AND NT-PRO BNP IN HEART FAILURE
Sukhjargalan Ch ; Tsolmon O ; Mend-Amar R ; Odgerel Ts
Innovation 2018;12(2):20-25
		                        		
		                        			
		                        			BACKGROUND. Previous retrospective study from our team showed that RDW significantly increased in chronic heart failure (CHF).
OBJECTIVE. The aim of the study was to compare the value of RDW-CV with NT-pro BNP and evaluate sensitivity and specificity of RDW for diagnose of heart failure.
MATEREALS AND METHOD. Here, we analyzed 20 patients who were suffering from heart failure and were treated in the department of Cardiology, First Clinical Hospital between in June 2017. All patients in the study group were underwent a complete blood count, immunoassay for NT-proBNP. The ejection fraction was analyzed by ECHO cardiograpy.
RESULTS. 85.0% of patients were male and remained was female. RBC and RDW was significantly differentially measured in between CHF groups (р= 0.028 p=0.0001). In control groups without heart failure NT-proBNP was estimated up to 100 pg/ml, whereas it was definitelly increased in patient with CHF (р=0.0001). There was strong correlation between RDW and NT-proBNP (r =0.846, p=0.0001). sensitivity and specificity of RDW was 89%, and 74.3 % respectively in CHF.
CONCLUSION. According to the our results there was direct correlation between RDW-CV and heart failure (p=0.035). RDW-CV migh be cost effective and routine laboratoty marker to evaulate CHF.
		                        		
		                        		
		                        		
		                        	
10.ТӨМӨР ДУТАГДЛЫГ ЭРТ ИЛРҮҮЛЭХЭД РЕТИКУЛОЦИТЫН ГЕМОГЛОБИНЫГ ТОДОРХОЙЛОХЫН АЧ ХОЛБОГДОЛ
Purevjal O ; Erdenebayar N ; Munkhbayarlakh S ; Bolor A ; Oyunkhand Ts ; Odgerel Ts
Innovation 2017;11(2):49-51
		                        		
		                        			
		                        			BACKGROUND. Regular blood donation can lead to pre-clinical iron deficiency as well as iron deficiency anemia. With Each donation donors lose 220-250 mg of iron. Early detection of iron deficiency is important for the blood donors and even useful for blood and blood product safety and supply. The research work we studied present Ret-HE to be used to detect the occurrence of iron deficiency eritrony level. Purpose: The aim of this study was to determine Ret-He to have sensitivity and specificity for diagnosing iron deficiency than traditional iron measurements. Materials and methods: We performed a cross sectional and case control study of 156 blood donors who served National Center for Transfusion Medicine. Ret-He, hemoglobin, plasma iron and ferritin were measured using XN2000 Sysmex, and CobasE600 Roche. The statistical analysis was done using One way Anova, Rock curve, Kruskal Wallis test. Results: We examined 64(41.02%) male donors, 92(58.9%) female donors by measurements of Ret-He,hemoglobin, serum, iron and ferritin. Survey participants were 8.33%(n=13) with anemia, 91.67% (n=143) without anemia. In donors with anemia the results were: RBC 4.9*106 u/l, HGB 10.8 g/dl (10;11), serum ferritin 5.2 (4.3; 6.3) mmol, serum iron 4.5 (3.7; 5.8) mmol and Ret-He 25.5 (22; 26) pg. Donors were divided into 3 age groups: group I age was up to 25years, group II was between 26-35 years, group III age criteria was above 35. Group I had serum iron 13.5 (10.; 18.), serum ferritin 41.8 (14; 78), Ret-He 32.2 (30; 33.) RBC 5×106 u/l (4.6;5), HGB14.2g/dl (13.3;14. 2). Group II had serum iron 14.6 (11; 19), serum ferritin 54.1 μg/l (29; 138), Ret-He 32.2pg (31; 33), RBC 5.1×106 u/l(4.7;5.1), HGB14.8 g/dl (13.5;14.8),Group III had serum iron 15.1 umol/l (9; 20), serum ferritin 95.7 μg/l (39; 141), Ret-He 32.7pg (31; 34) , RBC4.9×106 u/l(4.6;4.9), HGB 14.5g/dl(13.8;14.5), respectively. According to a curve (Roc) analysis, AUC of serum iron was 0.0963, serum ferritin 0.909, Ret-He 0.975. The mean Ret-He was 32.3pg (31.3;33.4). The optimal cut off value for the Ret-He was 29,25pg by ROC analysis and are presented along with sensitivity 92.3% and specificity 95.1%. Conclusion: 1. Determining the amount of Ret-He has a better sensitivity and specificity for diagnosing iron deficiency compared to traditional iron measurements.
2. Ret-He has diagnostic indicators that are able to detect the depletion of iron reserves, erythron level. And it need to be used in further clinical practices, as well as doctors should be required to use it for diagnosis and treatment.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail